| 000 | 01586 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513204212.0 | ||
| 264 | 0 | _c20000427 | |
| 008 | 200004s 0 0 eng d | ||
| 022 | _a0924-8579 | ||
| 024 | 7 |
_a10.1016/s0924-8579(99)00138-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKafetzis, D A | |
| 245 | 0 | 0 |
_aIsepamicin versus amikacin for the treatment of acute pyelonephritis in children. _h[electronic resource] |
| 260 |
_bInternational journal of antimicrobial agents _cFeb 2000 |
||
| 300 |
_a51-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmikacin _xpharmacokinetics |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aEscherichia coli _xisolation & purification |
| 650 | 0 | 4 |
_aEscherichia coli Infections _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGentamicins _xpharmacokinetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPyelonephritis _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUrine _xmicrobiology |
| 700 | 1 | _aMaltezou, H C | |
| 700 | 1 | _aMavrikou, M | |
| 700 | 1 | _aSiafas, C | |
| 700 | 1 | _aParaskakis, I | |
| 700 | 1 | _aDelis, D | |
| 700 | 1 | _aBartsokas, C | |
| 773 | 0 |
_tInternational journal of antimicrobial agents _gvol. 14 _gno. 1 _gp. 51-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0924-8579(99)00138-7 _zAvailable from publisher's website |
| 999 |
_c10671377 _d10671377 |
||